Low-priced stocks offer smaller investors the chance to not only make a tidy profit (as these stocks can provide the largest short-term gains), but also to acquire a higher share count than they would be able to of large and mega-cap stocks. Today’s article highlights five low-priced (trading under $10) biotech stocks that analysts see as having solid upside potential. For these five biotechs – including two potential takeover targets – that may be especially appealing to more aggressive traders, CLICK HERE.
5 Low-Priced Biotech Stocks For Big Share Counts – And Big Potential Gains
- by Bob Mitchell
Tags:Aggressive TradersBiotech StocksBiotech Stocks Under $10InvestLarge-Cap StocksLow Priced StocksMega-Cap StocksProfitsShare CountsSmaller InvestorsStock MarketTakeover TargetsTrading Under $10